Summary

The global CRISPR-associated Nucleases market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems, which form an adaptive immune system in bacteria, have been modified for genome engineering. CRISPR is a technology that can be employed to edit genes. Moreover, CRISPR technology has the potential to transform medicine and make us not only treat but also prevent many diseases.The core of CRISPR is the "Cas" proteins found in bacteria, where they help defend against viruses. CRISPR-associated (Cas) nucleases are furnishing transformative technologies for genome editing and functional genomics.
The Cas9 protein is the most commonly used by scientists. They recognize their substrate sequence via a Protospacer Adjacent Motif (PAM) sequence and base-pairing of the target sequence by a guide RNA (gRNA) borne by the nuclease. Upon target recognition, Cas nucleases induce a double-strand break, following which the cell's repair machinery can be co-opted to alter the genomic sequence.
The global CRISPR-associated Nucleases market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
China
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of CRISPR-associated Nucleases market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the CRISPR-associated Nucleases value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Cas9
1.2.3 Cas12
1.2.4 Cas13
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Gene Editing Cell Line Construction
1.3.3 Animal Models
1.3.4 Bioagriculture
1.3.5 Gene Therapy
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global CRISPR-associated Nucleases Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global CRISPR-associated Nucleases Market Share by Revenue, by Region (2021-2026)
2.4 Global CRISPR-associated Nucleases Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America CRISPR-associated Nucleases Market Size and Prospective (2021-2032)
2.5.2 Europe CRISPR-associated Nucleases Market Size and Prospective (2021-2032)
2.5.3 China CRISPR-associated Nucleases Market Size and Prospective (2021-2032)
2.5.4 Latin America CRISPR-associated Nucleases Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa CRISPR-associated Nucleases Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global CRISPR-associated Nucleases Historical Market Size by Type (2021-2026)
3.2 Global CRISPR-associated Nucleases Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of CRISPR-associated Nucleases

4 Breakdown Data by Application
4.1 Global CRISPR-associated Nucleases Historical Market Size by Application (2021-2026)
4.2 Global CRISPR-associated Nucleases Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in CRISPR-associated Nucleases Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top CRISPR-associated Nucleases Players by Revenue (2021-2026)
5.1.2 Global CRISPR-associated Nucleases Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by CRISPR-associated Nucleases Revenue
5.4 Global CRISPR-associated Nucleases Market Concentration Analysis
5.4.1 Global CRISPR-associated Nucleases Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by CRISPR-associated Nucleases Revenue in 2025
5.5 Global Key Players of CRISPR-associated Nucleases Head Offices and Areas Served
5.6 Global Key Players of CRISPR-associated Nucleases, Product and Application
5.7 Global Key Players of CRISPR-associated Nucleases, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America CRISPR-associated Nucleases Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America CRISPR-associated Nucleases Market Size by Type (2021-2026)
6.1.2.2 North America CRISPR-associated Nucleases Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America CRISPR-associated Nucleases Market Size by Application (2021-2026)
6.1.3.2 North America CRISPR-associated Nucleases Market Share by Application (2021-2026)
6.1.4 North America CRISPR-associated Nucleases Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe CRISPR-associated Nucleases Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe CRISPR-associated Nucleases Market Size by Type (2021-2026)
6.2.2.2 Europe CRISPR-associated Nucleases Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe CRISPR-associated Nucleases Market Size by Application (2021-2026)
6.2.3.2 Europe CRISPR-associated Nucleases Market Share by Application (2021-2026)
6.2.4 Europe CRISPR-associated Nucleases Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China CRISPR-associated Nucleases Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China CRISPR-associated Nucleases Market Size by Type (2021-2026)
6.3.2.2 China CRISPR-associated Nucleases Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China CRISPR-associated Nucleases Market Size by Application (2021-2026)
6.3.3.2 China CRISPR-associated Nucleases Market Share by Application (2021-2026)
6.3.4 China CRISPR-associated Nucleases Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America CRISPR-associated Nucleases Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America CRISPR-associated Nucleases Market Size by Type (2021-2026)
6.4.2.2 Latin America CRISPR-associated Nucleases Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America CRISPR-associated Nucleases Market Size by Application (2021-2026)
6.4.3.2 Latin America CRISPR-associated Nucleases Market Share by Application (2021-2026)
6.4.4 Latin America CRISPR-associated Nucleases Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa CRISPR-associated Nucleases Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa CRISPR-associated Nucleases Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa CRISPR-associated Nucleases Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa CRISPR-associated Nucleases Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa CRISPR-associated Nucleases Market Share by Application (2021-2026)
6.5.4 Middle East & Africa CRISPR-associated Nucleases Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific CRISPR-associated Nucleases Introduction
7.1.4 Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 GenScript
7.2.1 GenScript Company Details
7.2.2 GenScript Business Overview
7.2.3 GenScript CRISPR-associated Nucleases Introduction
7.2.4 GenScript Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.2.5 GenScript Recent Development
7.3 Integrated DNA Technologies, Inc.
7.3.1 Integrated DNA Technologies, Inc. Company Details
7.3.2 Integrated DNA Technologies, Inc. Business Overview
7.3.3 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Introduction
7.3.4 Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.3.5 Integrated DNA Technologies, Inc. Recent Development
7.4 Aldevron
7.4.1 Aldevron Company Details
7.4.2 Aldevron Business Overview
7.4.3 Aldevron CRISPR-associated Nucleases Introduction
7.4.4 Aldevron Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.4.5 Aldevron Recent Development
7.5 Merck
7.5.1 Merck Company Details
7.5.2 Merck Business Overview
7.5.3 Merck CRISPR-associated Nucleases Introduction
7.5.4 Merck Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.5.5 Merck Recent Development
7.6 Horizon Discovery
7.6.1 Horizon Discovery Company Details
7.6.2 Horizon Discovery Business Overview
7.6.3 Horizon Discovery CRISPR-associated Nucleases Introduction
7.6.4 Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.6.5 Horizon Discovery Recent Development
7.7 Agilent
7.7.1 Agilent Company Details
7.7.2 Agilent Business Overview
7.7.3 Agilent CRISPR-associated Nucleases Introduction
7.7.4 Agilent Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.7.5 Agilent Recent Development
7.8 OriGene Technologies, Inc
7.8.1 OriGene Technologies, Inc Company Details
7.8.2 OriGene Technologies, Inc Business Overview
7.8.3 OriGene Technologies, Inc CRISPR-associated Nucleases Introduction
7.8.4 OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.8.5 OriGene Technologies, Inc Recent Development
7.9 New England Biolabs
7.9.1 New England Biolabs Company Details
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs CRISPR-associated Nucleases Introduction
7.9.4 New England Biolabs Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.9.5 New England Biolabs Recent Development
7.10 NIPPON GENE CO., LTD.
7.10.1 NIPPON GENE CO., LTD. Company Details
7.10.2 NIPPON GENE CO., LTD. Business Overview
7.10.3 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Introduction
7.10.4 NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.10.5 NIPPON GENE CO., LTD. Recent Development
7.11 Novoprotein
7.11.1 Novoprotein Company Details
7.11.2 Novoprotein Business Overview
7.11.3 Novoprotein CRISPR-associated Nucleases Introduction
7.11.4 Novoprotein Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.11.5 Novoprotein Recent Development
7.12 Applied Biological Materials Inc. (abm)
7.12.1 Applied Biological Materials Inc. (abm) Company Details
7.12.2 Applied Biological Materials Inc. (abm) Business Overview
7.12.3 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Introduction
7.12.4 Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2021-2026)
7.12.5 Applied Biological Materials Inc. (abm) Recent Development

8 CRISPR-associated Nucleases Market Dynamics
8.1 CRISPR-associated Nucleases Industry Trends
8.2 CRISPR-associated Nucleases Market Drivers
8.3 CRISPR-associated Nucleases Market Challenges
8.4 CRISPR-associated Nucleases Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global CRISPR-associated Nucleases Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global CRISPR-associated Nucleases Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market CRISPR-associated Nucleases Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global CRISPR-associated Nucleases Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global CRISPR-associated Nucleases Revenue Share by Region (2021-2026)
Table 6. Global CRISPR-associated Nucleases Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global CRISPR-associated Nucleases Revenue Share Forecast by Region (2027-2032)
Table 8. Global CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global CRISPR-associated Nucleases Market Share by Revenue, by Type (2021-2026)
Table 10. Global CRISPR-associated Nucleases Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global CRISPR-associated Nucleases Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global CRISPR-associated Nucleases Market Share by Revenue, by Application (2021-2026)
Table 15. Global CRISPR-associated Nucleases Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global CRISPR-associated Nucleases Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in CRISPR-associated Nucleases Applications
Table 18. Global CRISPR-associated Nucleases Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global CRISPR-associated Nucleases Market Share by Players (2021-2026)
Table 20. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2025)
Table 21. Ranking of Global Top CRISPR-associated Nucleases Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by CRISPR-associated Nucleases Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of CRISPR-associated Nucleases, Headquarters and Area Served
Table 24. Global Key Players of CRISPR-associated Nucleases, Product and Application
Table 25. Global Key Players of CRISPR-associated Nucleases, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America CRISPR-associated Nucleases Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America CRISPR-associated Nucleases Market Share by Revenue, by Company (2021-2026)
Table 29. North America CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe CRISPR-associated Nucleases Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe CRISPR-associated Nucleases Market Share by Revenue, by Company (2021-2026)
Table 33. Europe CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 35. China CRISPR-associated Nucleases Revenue by Company (2021-2026) & (US$ Million)
Table 36. China CRISPR-associated Nucleases Market Share by Revenue, by Company (2021-2026)
Table 37. China CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 38. China CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America CRISPR-associated Nucleases Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America CRISPR-associated Nucleases Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa CRISPR-associated Nucleases Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa CRISPR-associated Nucleases Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa CRISPR-associated Nucleases Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa CRISPR-associated Nucleases Market Size by Application (2021-2026) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific CRISPR-associated Nucleases Product
Table 50. Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. GenScript Company Details
Table 53. GenScript Business Overview
Table 54. GenScript CRISPR-associated Nucleases Product
Table 55. GenScript Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 56. GenScript Recent Development
Table 57. Integrated DNA Technologies, Inc. Company Details
Table 58. Integrated DNA Technologies, Inc. Business Overview
Table 59. Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Product
Table 60. Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 61. Integrated DNA Technologies, Inc. Recent Development
Table 62. Aldevron Company Details
Table 63. Aldevron Business Overview
Table 64. Aldevron CRISPR-associated Nucleases Product
Table 65. Aldevron Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 66. Aldevron Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck CRISPR-associated Nucleases Product
Table 70. Merck Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Horizon Discovery Company Details
Table 73. Horizon Discovery Business Overview
Table 74. Horizon Discovery CRISPR-associated Nucleases Product
Table 75. Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 76. Horizon Discovery Recent Development
Table 77. Agilent Company Details
Table 78. Agilent Business Overview
Table 79. Agilent CRISPR-associated Nucleases Product
Table 80. Agilent Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. OriGene Technologies, Inc Company Details
Table 83. OriGene Technologies, Inc Business Overview
Table 84. OriGene Technologies, Inc CRISPR-associated Nucleases Product
Table 85. OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 86. OriGene Technologies, Inc Recent Development
Table 87. New England Biolabs Company Details
Table 88. New England Biolabs Business Overview
Table 89. New England Biolabs CRISPR-associated Nucleases Product
Table 90. New England Biolabs Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 91. New England Biolabs Recent Development
Table 92. NIPPON GENE CO., LTD. Company Details
Table 93. NIPPON GENE CO., LTD. Business Overview
Table 94. NIPPON GENE CO., LTD. CRISPR-associated Nucleases Product
Table 95. NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 96. NIPPON GENE CO., LTD. Recent Development
Table 97. Novoprotein Company Details
Table 98. Novoprotein Business Overview
Table 99. Novoprotein CRISPR-associated Nucleases Product
Table 100. Novoprotein Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 101. Novoprotein Recent Development
Table 102. Applied Biological Materials Inc. (abm) Company Details
Table 103. Applied Biological Materials Inc. (abm) Business Overview
Table 104. Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Product
Table 105. Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2021-2026) & (US$ Million)
Table 106. Applied Biological Materials Inc. (abm) Recent Development
Table 107. CRISPR-associated Nucleases Market Trends
Table 108. CRISPR-associated Nucleases Market Drivers
Table 109. CRISPR-associated Nucleases Market Challenges
Table 110. CRISPR-associated Nucleases Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List of Figures
Figure 1. CRISPR-associated Nucleases Product Picture
Figure 2. Global CRISPR-associated Nucleases Market Share by Type: 2025 vs 2032
Figure 3. Cas9 Features
Figure 4. Cas12 Features
Figure 5. Cas13 Features
Figure 6. Others Features
Figure 7. Global CRISPR-associated Nucleases Market Share by Application: 2025 vs 2032
Figure 8. Gene Editing Cell Line Construction
Figure 9. Animal Models
Figure 10. Bioagriculture
Figure 11. Gene Therapy
Figure 12. Other
Figure 13. CRISPR-associated Nucleases Report Years Considered
Figure 14. Global CRISPR-associated Nucleases Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global CRISPR-associated Nucleases Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global CRISPR-associated Nucleases Market Share by Revenue, by Region: 2021 vs 2025
Figure 17. North America CRISPR-associated Nucleases Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Europe CRISPR-associated Nucleases Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. China CRISPR-associated Nucleases Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Latin America CRISPR-associated Nucleases Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Middle East & Africa CRISPR-associated Nucleases Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. Global CRISPR-associated Nucleases Market Share by Players in 2025
Figure 23. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2025)
Figure 24. The Top 10 and 5 Players Market Share by CRISPR-associated Nucleases Revenue in 2025
Figure 25. North America CRISPR-associated Nucleases Market Share by Type (2021-2026)
Figure 26. North America CRISPR-associated Nucleases Market Share by Application (2021-2026)
Figure 27. Europe CRISPR-associated Nucleases Market Share by Type (2021-2026)
Figure 28. Europe CRISPR-associated Nucleases Market Share by Application (2021-2026)
Figure 29. China CRISPR-associated Nucleases Market Share by Type (2021-2026)
Figure 30. China CRISPR-associated Nucleases Market Share by Application (2021-2026)
Figure 31. Latin America CRISPR-associated Nucleases Market Share by Type (2021-2026)
Figure 32. Latin America CRISPR-associated Nucleases Market Share by Application (2021-2026)
Figure 33. Middle East & Africa CRISPR-associated Nucleases Market Share by Type (2021-2026)
Figure 34. Middle East & Africa CRISPR-associated Nucleases Market Share by Application (2021-2026)
Figure 35. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 36. GenScript Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 37. Integrated DNA Technologies, Inc. Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 38. Aldevron Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 39. Merck Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 40. Horizon Discovery Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 41. Agilent Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 42. OriGene Technologies, Inc Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 43. New England Biolabs Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 44. NIPPON GENE CO., LTD. Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 45. Novoprotein Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 46. Applied Biological Materials Inc. (abm) Revenue Growth Rate in CRISPR-associated Nucleases Business (2021-2026)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed